Gabelli Funds LLC Incyte Corp Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Incyte Corp stock. As of the latest transaction made, Gabelli Funds LLC holds 15,237 shares of INCY stock, worth $1.07 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,237

Previous 15,237 -0.0%

Holding current value

$1.07 Million

Previous $923,000 9.1%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$51.18 - $63.75 $53,073 - $66,108	1,037 Added 7.3%	15,237 $923,000
Q1 2024 May 14, 2024	SELL	$56.55 - $66.59 $33,930 - $39,954	-600 Reduced 4.05%	14,200 $808,000
Q4 2023 Feb 13, 2024	SELL	$52.16 - $64.19 $62,591 - $77,028	-1,200 Reduced 7.5%	14,800 $929,000
Q1 2023 May 12, 2023	SELL	$70.23 - $86.01 $28,092 - $34,404	-400 Reduced 2.44%	16,000 $1.16 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $47,026 - $58,877	700 Added 4.46%	16,400 $1.32 Million
Q3 2022 Nov 10, 2022	SELL	$66.18 - $82.86 $19,854 - $24,858	-300 Reduced 1.88%	15,700 $1.05 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $33,090 - $41,590	-500 Reduced 3.03%	16,000 $1.22 Million
Q1 2022 May 13, 2022	BUY	$66.02 - $79.71 $13,204 - $15,941	200 Added 1.23%	16,500 $1.31 Million
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $95,516 - $111,757	1,508 Added 10.19%	16,300 $1.2 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $206,010 - $252,060	3,000 Added 25.44%	14,792 $1.02 Million
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $79,870 - $87,530	-1,000 Reduced 7.82%	11,792 $992,000
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $98,217 - $129,846	1,292 Added 11.23%	12,792 $1.04 Million
Q4 2020 Feb 05, 2021	BUY	$80.74 - $97.7 $40,370 - $48,850	500 Added 4.55%	11,500 $1 Million
Q3 2020 Nov 06, 2020	SELL	$85.07 - $109.69 $382,814 - $493,605	-4,500 Reduced 29.03%	11,000 $987,000
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $333,810 - $490,185	-4,500 Reduced 22.5%	15,500 $1.61 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $410,670 - $558,805	-6,500 Reduced 24.53%	20,000 $1.47 Million
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $146,080 - $191,440	-2,000 Reduced 7.02%	26,500 $2.31 Million
Q2 2019 Aug 02, 2019	SELL	$73.52 - $88.7 $66,168 - $79,830	-900 Reduced 3.06%	28,500 $2.42 Million
Q1 2019 May 02, 2019	SELL	$63.56 - $88.17 $381,360 - $529,020	-6,000 Reduced 16.95%	29,400 $2.53 Million
Q4 2018 Jan 30, 2019	SELL	$58.5 - $69.94 $87,750 - $104,910	-1,500 Reduced 4.07%	35,400 $2.25 Million
Q3 2018 Nov 02, 2018	BUY	$61.75 - $74.23 $61,750 - $74,230	1,000 Added 2.79%	36,900 $2.55 Million
Q2 2018 Aug 10, 2018	SELL	$60.85 - $83.98 $483,757 - $667,641	-7,950 Reduced 18.13%	35,900 $2.41 Million
Q1 2018 May 09, 2018	BUY	$83.06 - $100.98 $1.02 Million - $1.24 Million	12,300 Added 38.99%	43,850 $3.65 Million
Q4 2017 Feb 02, 2018	BUY	$93.56 - $116.6 $823,328 - $1.03 Million	8,800 Added 38.68%	31,550 $2.99 Million
Q3 2017 Nov 01, 2017	BUY	$109.15 - $138.27 $2.48 Million - $3.15 Million	22,750	22,750 $2.66 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Incyte Corp Transaction History